AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2670019
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (medroxyprogesterone 10 mg/day for 12 days)
Trial: 28119433
Drug: AURAS‐AF software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AURAS‐AF software tool for automated risk assessment and reminders for OAC treatment.
Trial: 26153191
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of mean depression level at post treatment between both groups.
Trial: 24350936
Drug: Control (other
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (other oral antidiabetic agents)
Trial: 15111514
Drug: Human Soluble
RxNorm normalized name: Recombinant human soluble insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human Soluble Insulin (HI)
Trial: 2892260
Drug: Nizatidine 150
RxNorm normalized name: nizatidine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 150 mg
Trial: 12180579
Drug: Nizatidine 300
RxNorm normalized name: nizatidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 300 mg
Trial: 2801224
Drug: Antibiotics (trimethoprim)
RxNorm normalized name: Trimethoprim
DrugBank: Trimethoprim (DB00440)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotics (trimethoprim) given as single dose or as a conventional 7-day regime
Trial: 794090
Drug: 0.05% solution
RxNorm normalized name: Equate Nasal Spray 0.05% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% solution of N-monochloroglycine (GK-101) applied under pressure
Trial: 8651535
Drug: Placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo solution of normal saline
Trial: 794090
Drug: GK-101 solution
RxNorm normalized name: penicillin G
DrugBank: Benzylpenicillin (DB01053)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GK-101 solution in conjunction with the pump system
Trial: 794090
Drug: GK-101 solution
RxNorm normalized name: penicillin G
DrugBank: Benzylpenicillin (DB01053)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GK-101 solution
Trial: 19935122
Drug: Tobramycin 0.3%,
RxNorm normalized name: Tobramycin 0.3%, Dexamethasone 0.1% Ophthalmic drops, suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin 0.3%, 1 drop every 2 hours for 2 days then 4 times daily for 5 days
Trial: 17687151
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (CR)
Trial: 12096449
Drug: Cognitive‐behavioural treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioural treatment combined with interventions designed to improve treatment compliance
Trial: 12096449
Drug: Cognitive‐behavioural treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioural treatment
Trial: 2297107
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural fentanyl infusion
Trial: 2297107
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous fentanyl infusion
Trial: 31280470
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 70 µg/day
Trial: 2166377
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg enoxaparin
Trial: 2166377
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg enoxaparin
Trial: 21909736
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg enoxaparin (in-hospital)
Trial: 21909736
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg enoxaparin (in-hospital)
Trial: 25804941
Drug: G-CSF plus
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF plus plerixafor
Trial: 23333777
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus G-CSF
Trial: 31891833
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of alcohol (mean BAC: 0.03 g/dL) during moped riding simulation
Trial: 18420099
Drug: Ezetimibe/Simvastatin (10/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe/Simvastatin (10/20 mg/day) + Niacin (titrated to 2 g/day)
Trial: 18420099
Drug: Niacin (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin (titrated to 2 g/day)
Trial: 18420099
Drug: Ezetimibe/Simvastatin (10/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe/Simvastatin (10/20 mg/day)
Trial: 10837304
Drug: [57Fe]ferrous fumarate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [57Fe]ferrous fumarate with 25 mg ascorbic acid
Trial: 10837304
Drug: [57Fe]ferrous fumarate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [57Fe]ferrous fumarate with 50 mg ascorbic acid
Trial: 8463920
Drug: Herbal tea
RxNorm normalized name: Senna Oral Powder for Suspension [CORRECTOL HERBAL TEA LAXATIVE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal tea preparation
Trial: 2566321
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg)
Trial: 10806134
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg)
Trial: 27899107
Drug: Unplugged program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unplugged program (12 weekly classes)
Trial: 3565796
Drug: Aminophylline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (2 mg/kg)
Trial: 3565796
Drug: Physiologic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiologic saline (5 ml) - Control
Trial: 23982026
Drug: Light sedation
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light sedation (1.26 ± 0.35 μg/mL)
Trial: 23982026
Drug: Deep sedation
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep sedation (2.52 ± 0.71 μg/mL)
Trial: 15910382
Drug: Intravenous cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclosporine (CYS)
Trial: 16385545
Drug: Rofecoxib 25
RxNorm normalized name: rofecoxib 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 25 mg once daily
Trial: 10555907
Drug: Rofecoxib 125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 125 mg once daily
Trial: 25880964
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (people who inject drugs)
Trial: 23323566
Drug: Gastric contraction
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric contraction modulation treatment (TANTALUS-DIAMOND)
Trial: 15356042
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg) once daily for 6 months
Trial: 17543413
Drug: Placebo once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo once daily for 6 months
Trial: 2530191
Drug: Doxycycline 50
RxNorm normalized name: doxycycline 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 50 mg daily
Trial: 2530191
Drug: Minocycline 100
RxNorm normalized name: minocycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 100 mg daily (50 mg twice daily)
Trial: 22562960
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g testosterone gel daily for 6 months
Trial: 11412291
Drug: Propofol 3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3.5 mg kg(‐1)
Trial: 12631047
Drug: Thiopentone 5
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone 5 mg kg(‐1)
Trial: 12631047
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 mg kg(‐1)
Trial: 9180665
Drug: Felodipine ER
RxNorm normalized name: Felodipine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER 2.5 mg qd (increased to 5 mg qd after 3 weeks and to 10 mg qd after 6 weeks if SDBP > 90 mm Hg)
Trial: 1609548
Drug: DTP-PRP/D vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP-PRP/D vaccine (109 children)
Trial: 1609548
Drug: DTP vaccine
RxNorm normalized name: DTP Vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP vaccine (66 children)
Trial: 4027146
Drug: Nicardipine (5-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (5-20 mg three times daily)
Trial: 4027146
Drug: Nicardipine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine and Atenolol combination
Trial: 31972657
Drug: Remimazolam continuous
RxNorm normalized name: remimazolam
DrugBank: Remimazolam (DB12404)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Remimazolam continuous IV infusion
Trial: 29803816
Drug: Individual medical
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual medical nutrition therapy (MNT)
Trial: 19573262
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment (Control)
Trial: 20418403
Drug: Beliefs about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beliefs about the influenza vaccine
Trial: 18041735
Drug: efavirenz 600
RxNorm normalized name: efavirenz 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: efavirenz 600 mg daily for 10 days with amprenavir 600 mg twice daily added at day 11
Trial: 16025964
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (western medicine plus double faced blue treatment)
Trial: 10799372
Drug: High-dose BCS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose BCS (approximately 45 g)
Trial: 10799372
Drug: Low-dose BCS
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose BCS (approximately 25 g)
Trial: 8625493
Drug: Diet C
RxNorm normalized name: Diet Caplets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet C (12 day dietary supplement to the standard diet of 500 g/day broccoli)
Trial: 1453032
Drug: Metronidazole (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (1000 mg)
Trial: 3894277
Drug: Mitoxantrone (14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitoxantrone (14 mg/m2)
Trial: 3894277
Drug: Bisantrene (260
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisantrene (260 mg/m2)
Trial: 28181386
Drug: In-home rehabilitation
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: In-home rehabilitation (physical treatment program once a week and basic nursing care)
Trial: 21790771
Drug: Sedation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedation with xylazine (0.5 mg/kg bwt, iv)
Trial: 11237056
Drug: Idarubicin (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idarubicin (12 mg/m2/day for 3 days)
Trial: 11237056
Drug: Daunorubicin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daunorubicin (60 mg/m2/day for 3 days)
Trial: 9552042
Drug: CC arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CC arm (Carboplatin and Cisplatin)
Trial: 3286068
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid 1 g, 3 times daily for 10 days
Trial: 29875024
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy (GDT) guided by esophageal Doppler monitoring
Trial: 21770897
Drug: L-carnitine (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (0.05 g/kg) administered with a rapid infusion diluted in 250 ml of saline solution
Trial: 16980000
Drug: High-dose TMP/SXT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose TMP/SXT (320/1600 mg, daily in two divided doses)
Trial: 16980000
Drug: Low to
RxNorm normalized name: Mutton Tallow Topical application Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low to moderate doses of TMP/SXT (either 80/400 mg or 160/800 mg, daily)
Trial: 15250200
Drug: Nitrate ester
RxNorm normalized name: lutein esters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate ester preparation
Trial: 11059223
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with V.D3 and etidronate (group B)
Trial: 11059223
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with active vitamin D3 (group A)
Trial: 8418608
Drug: Amoxicillin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (40 mg/kg per day administered in three divided doses)
Trial: 3614304
Drug: Calcium acetate
RxNorm normalized name: Calcium Acetate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium acetate (500 mg)
Trial: 3614304
Drug: Calcium lactate
RxNorm normalized name: Calcium Lactate
DrugBank: Calcium lactate (DB13231)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium lactate (500 mg)
Trial: 3614304
Drug: Calcium gluconate
RxNorm normalized name: Calcium Gluconate
DrugBank: Calcium gluconate (DB11126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium gluconate (500 mg)
Trial: 18553042
Drug: Calcium citrate
RxNorm normalized name: Calcium Citrate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium citrate (500 mg)
Trial: 3614304
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (500 mg)
Trial: 22995802
Drug: Aliskiren 300
RxNorm normalized name: aliskiren 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 300 mg daily (A)
Trial: 22995802
Drug: Valsartan 320
RxNorm normalized name: valsartan 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 320 mg daily (V)
Trial: 22995802
Drug: Aliskiren 150
RxNorm normalized name: aliskiren 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 150 mg + Valsartan 160 mg daily (A+V)
Trial: 19080096
Drug: BIS monitoring
RxNorm normalized name: bis-ethoxydiglycol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIS monitoring during intravenous anesthesia with remifentanil and propofol
Trial: 9068739
Drug: erythromycin 4%/zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: erythromycin 4%/zinc 1.2% solution
Trial: 3535492
Drug: Oral capsules
RxNorm normalized name: Plenity Oral Capsules
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral capsules of potassium metabisulfite
Trial: 3535492
Drug: Double-blind rechallenge
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-blind rechallenge with metabisulfite capsules
Trial: 9246276
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol anaesthesia
Trial: 19783710
Drug: Sitagliptin 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 200 mg/d for 11 days + Warfarin 30 mg on day 5
Trial: 19783710
Drug: Warfarin 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin 30 mg alone on day 1
Trial: 17357336
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg 'on-demand'
Trial: 8943962
Drug: Lansoprazole 15
RxNorm normalized name: lansoprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 15 mg daily
Trial: 17357336
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg in four-week courses during a relapse
Trial: 12727707
Drug: DHA, 2
RxNorm normalized name: Prenatal DHA, 200 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA, 2 g/day for 6 weeks
Trial: 8842054
Drug: Nadolol 160mg
RxNorm normalized name: NADOLOL 160MG TAB
DrugBank: Nadolol (DB01203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nadolol 160mg tablet (Zenith‐Goldline Pharmaceuticals)
Trial: 8842054
Drug: Nadolol 40mg
RxNorm normalized name: NADOLOL 40MG TAB
DrugBank: Nadolol (DB01203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nadolol 40mg tablet (Zenith‐Goldline Pharmaceuticals)
Trial: 8842054
Drug: Nadolol 40mg
RxNorm normalized name: NADOLOL 40MG TAB
DrugBank: Nadolol (DB01203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nadolol 40mg tablet (80mg dose)
Trial: 22926607
Drug: oral CYT
RxNorm normalized name: CYT-6091
DrugBank: CYT-6091 (DB05991)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral CYT + O3FA (2 g O3FA twice a day, 1 g CYT twice a day)
Trial: 22926607
Drug: placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo + O3FA (2 g O3FA twice a day)
Trial: 18796095
Drug: peginterferon alfa-2a
RxNorm normalized name: Peginterferon Alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: peginterferon alfa-2a (40KD) plus ribavirin (1,000/1,200 mg/day)
Trial: 15654292
Drug: Mecamylamine (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mecamylamine (7.5 mg)
Trial: 15201697
Drug: Diazoxide (DZX)
DrugBank: Diazoxide (DB01119)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diazoxide (DZX) 1.5 mg/kg infused intravenously in 5 min followed by a 5‐min washout before cardiopulmonary bypass.
Trial: 15201697
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received placebo infusion.
Trial: 11102590
Drug: Testosterone implants
RxNorm normalized name: testosterone Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone implants (800-1200 mg every 3 months)
Trial: 11102590
Drug: Testosterone implants
RxNorm normalized name: testosterone Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone implants (800 mg) with finasteride (5alpha-reductase inhibitor)
Trial: 8165591
Drug: Isotretinoin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin (40 mg) administered in the morning and evening for 5 days
Trial: 16815137
Drug: 100/50 microg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100/50 microg of fluticasone propionate/salmeterol administered through a Diskus inhaler twice daily for 24 weeks
Trial: 16815137
Drug: 250 microg
RxNorm normalized name: Digoxin 250 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 microg of fluticasone propionate administered through a Diskus inhaler twice daily for 24 weeks
Trial: 9103129
Drug: Propafenone (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone (500 mg oral dose)
Trial: 3542826
Drug: Isotonic amino
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic amino acid solution
Trial: 12622501
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg disintegrating tablets, administered orally every 12 hours for 3 days
Trial: 12622501
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered orally every 12 hours for 3 days
Trial: 10374221
Drug: Estrogen treatment
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen treatment
Trial: 22929568
Drug: standard abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: standard abciximab infusion (A)
Trial: 22929568
Drug: thrombectomy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: thrombectomy followed by abciximab infusion with the ClearWay catheter (T+C)
Trial: 18720328
Drug: Betahistine 3x12
RxNorm normalized name: betahistine
DrugBank: Betahistine (DB06698)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betahistine 3x12 mg
Trial: 17361524
Drug: Chibixiao Recipe
RxNorm normalized name: SALICYLIC ACID 1 g in 100 mL TOPICAL SHAMPOO [Maetria Miracle Recipe PremiumShampoo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chibixiao Recipe (CBX) in combination with minocycline and spironolactone
Trial: 8910149
Drug: Albunex (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albunex (2 to 8 mL injected before and after coronary revascularization)
Trial: 1725447
Drug: Lacidipine 4
RxNorm normalized name: lacidipine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine 4 mg p.o. once daily
Trial: 6617205
Drug: i.m. norethisterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. norethisterone enanthate (NET‐e) 200 mg every two months
Trial: 6617205
Drug: Oral combination
RxNorm normalized name: clozapine ORAL COMBINATION PACKAGE (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral combination of 1-norgestrel 150 micrograms and ethinyl estradiol 30 micrograms
Trial: 26674292
Drug: Spa treatment
RxNorm normalized name: Salicylic Acid 5 mg in 1 mL TOPICAL LOTION [ageLOC LumiSpa Treatment Cleanser Acne]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa treatment (procedures and drinking cure)
Trial: 24703722
Drug: Itolizumab arm
RxNorm normalized name: ibalizumab
DrugBank: Ibalizumab (DB12698)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Itolizumab arm A (4-week loading dose of 0.4 mg/kg/wk followed by 1.6 mg/kg every 2 weeks)